Theseus Pharmaceuticals Statistics
Total Valuation
ImagineAR has a market cap or net worth of 6.22 million. The enterprise value is 6.23 million.
| Market Cap | 6.22M |
| Enterprise Value | 6.23M |
Important Dates
The last earnings date was Friday, July 25, 2025.
| Earnings Date | Jul 25, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 285.95M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +12.37% |
| Shares Change (QoQ) | +2.97% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 278.40M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 285.06 |
| PB Ratio | -3.85 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.67 |
| EV / Sales | 286.11 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.17
| Current Ratio | 0.17 |
| Quick Ratio | 0.14 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -761.42% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 159.31% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.12 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +37.25% in the last 52 weeks. The beta is 2.20, so ImagineAR's price volatility has been higher than the market average.
| Beta (5Y) | 2.20 |
| 52-Week Price Change | +37.25% |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.04 |
| Relative Strength Index (RSI) | 48.66 |
| Average Volume (20 Days) | 42,729 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ImagineAR had revenue of 21,834 and -2.33 million in losses. Loss per share was -0.01.
| Revenue | 21,834 |
| Gross Profit | -84,524 |
| Operating Income | -2.19M |
| Pretax Income | -2.33M |
| Net Income | -2.33M |
| EBITDA | n/a |
| EBIT | -2.19M |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 230,288 in cash and 240,792 in debt, giving a net cash position of -10,503.
| Cash & Cash Equivalents | 230,288 |
| Total Debt | 240,792 |
| Net Cash | -10,503 |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -1.62M |
| Book Value Per Share | -0.01 |
| Working Capital | -1.38M |
Cash Flow
| Operating Cash Flow | -713,570 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | -10,035.11% |
| Pretax Margin | -10,683.33% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ImagineAR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -12.37% |
| Shareholder Yield | n/a |
| Earnings Yield | -37.48% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 20, 2015. It was a reverse split with a ratio of 0.1.
| Last Split Date | Jul 20, 2015 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
ImagineAR has an Altman Z-Score of -208.65 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -208.65 |
| Piotroski F-Score | 2 |